CSIMarket
 


Scynexis inc   (SCYX)
Other Ticker:  
 

Scynexis Inc 's Working Capital Ratio

SCYX's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth




SCYX Working Capital Ratio (Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
Y / Y Current Liabilities Change 171.72 % 255.46 % 140.44 % 2.44 % 1.33 %
Y / Y Current Assets Change 185.04 % 159.24 % 87.41 % 11.57 % 12.24 %
Working Capital Ratio MRQ 5.82 3.83 3.72 3.91 5.54
Overall Ranking # # # # #
Seq. Current Liabilities Change -20.27 % -5.55 % 219.64 % 12.88 % 4.31 %
Seq. Current Assets Change 21.24 % -2.88 % 203.94 % -20.35 % 10.27 %



Working Capital Ratio second quarter 2021 Comment
Scynexis Inc 's Current Assets grew by 21.24 % in II. Quarter sequntially, while Current Liabilities decreased, this led to improvement in Scynexis Inc 's Working Capital Ratio to 5.82, Working Capital Ratio remained below Scynexis inc average.

Within Major Pharmaceutical Preparations industry 219 other companies have achieved higher Working Capital Ratio than Scynexis Inc in second quarter 2021. While total ranking remained unchanged compare to previous quarter at no. .

Explain Working Capital Ratio
Where is SCYX most successful ?
Working Capital Ratio SCYX on the trailing twelve month basis
Working Capital Ratio second quarter 2021 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 220
Healthcare Sector # 456
Overall Market # 1176


Working Capital Ratio Statistics
High Average Low
21.61 8.06 0.29
(Sep 30 2015)   (Mar 31 2014)




Financial Statements
Scynexis Inc 's Current Liabilities $ 20 Millions Visit SCYX's Balance sheet
Scynexis Inc 's Current Assets $ 116 Millions Visit SCYX's Balance sheet
Source of SCYX's Sales Visit SCYX's Sales by Geography




Companies with similar Working Capital Ratio in the quarter endingJun 30 2021, within Major Pharmaceutical Preparations Industry Working Capital RatioJun 30 2021 MRQ Current AssetsJun 30 2021 MRQ Current Liabilities
Siga Technologies Inc  15.94 $ 127.066  Millions$ 7.971  Millions
Edesa Biotech Inc   15.86 $ 14.334  Millions$ 0.904  Millions
Diamedica Therapeutics Inc   15.78 $ 21.629  Millions$ 1.371  Millions
Sio Gene Therapies Inc   15.66 $ 118.933  Millions$ 7.595  Millions
Concert Pharmaceuticals Inc   15.34 $ 132.983  Millions$ 8.670  Millions
Oncorus Inc   15.14 $ 162.689  Millions$ 10.744  Millions
Arvinas Inc   15.01 $ 627.734  Millions$ 41.820  Millions
Cyclacel Pharmaceuticals Inc   14.82 $ 46.203  Millions$ 3.118  Millions
Avadel Pharmaceuticals Plc  14.61 $ 230.702  Millions$ 15.786  Millions
Abcellera Biologics Inc   14.60 $ 864.002  Millions$ 59.190  Millions
Hoth Therapeutics Inc  14.41 $ 17.569  Millions$ 1.219  Millions
Akero Therapeutics inc   14.35 $ 236.222  Millions$ 16.459  Millions
Recro Pharma Inc   14.29 $ 75.793  Millions$ 5.303  Millions
Vanda Pharmaceuticals Inc   14.05 $ 446.652  Millions$ 31.788  Millions
Cellectar Biosciences Inc   13.90 $ 47.125  Millions$ 3.391  Millions
Xoma Corporation  13.88 $ 87.251  Millions$ 6.287  Millions
Enanta Pharmaceuticals Inc  13.61 $ 321.155  Millions$ 23.590  Millions
Atreca inc   13.48 $ 192.890  Millions$ 14.307  Millions
Repare Therapeutics Inc   13.31 $ 309.188  Millions$ 23.223  Millions
Allogene Therapeutics Inc   13.09 $ 602.171  Millions$ 45.998  Millions
Oramed Pharmaceuticals Inc   12.85 $ 72.233  Millions$ 5.621  Millions
Synlogic Inc   12.74 $ 122.681  Millions$ 9.633  Millions
Cymabay Therapeutics Inc   12.70 $ 113.813  Millions$ 8.959  Millions
Morphic Holding inc   12.51 $ 436.846  Millions$ 34.912  Millions
Aurinia Pharmaceuticals Inc   12.40 $ 349.689  Millions$ 28.203  Millions
Phio Pharmaceuticals Corp   12.08 $ 31.155  Millions$ 2.578  Millions
Gt Biopharma Inc  12.08 $ 39.567  Millions$ 3.276  Millions
Intra cellular Therapies Inc   11.93 $ 601.303  Millions$ 50.422  Millions
Y mabs Therapeutics inc   11.88 $ 249.369  Millions$ 20.986  Millions
Seelos Therapeutics Inc   11.88 $ 90.246  Millions$ 7.595  Millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CLIR's Profile

Stock Price

CLIR's Financials

Business Description

Fundamentals

Charts & Quotes

CLIR's News

Suppliers

CLIR's Competitors

Customers & Markets

Economic Indicators

CLIR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071